Analysis

Walt Disney (DIS) all set to report Q4 earnings. Here’s what to expect

Entertainment behemoth The Walt Disney Company (NYSE: DIS) is scheduled to report fourth-quarter results on the morning of November 14, after turning

Hasbro (HAS): A few strategic changes the toymaker is implementing to drive growth

Shares of Hasbro, Inc. (NASDAQ: HAS) fell over 5% on Wednesday. The stock has gained 23% year-to-date. The toymaker saw revenues decline

Earnings Preview: How the new fiscal year is shaping up for Cisco (CSCO)

For Cisco Systems Inc. (NASDAQ: CSCO), fiscal 2024 was a momentous year with strong order growth and an upswing in gross margins,

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced third-quarter 2024 results, reporting a decrease in adjusted earnings and an increase in revenues. The top line exceeded estimates. September-quarter

November 6, 2024

Earnings Preview: How the new fiscal year is shaping up for Cisco (CSCO)

For Cisco Systems Inc. (NASDAQ: CSCO), fiscal 2024 was a momentous year with strong order growth and an upswing in gross margins, although sales and profit for the year declined

November 5, 2024

What to expect when Tyson Foods (TSN) reports its Q4 2024 earnings results

Shares of Tyson Foods, Inc. (NYSE: TSN) stayed green on Tuesday. The stock has gained 9% year-to-date. The food company is scheduled to report its fourth quarter 2024 earnings results

November 5, 2024

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top